Chen, Hongmei <br/><br/>
Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9  [electronic resource] 

 -  Science advances  01 2020 
 - eaax4690 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2375-2548 
<br/><br/><label>Standard No.: </label>10.1126/sciadv.aax4690  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD47 Antigen--antagonists & inhibitors<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Chemokines, CC--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Immunotherapy<br/>Mice<br/>Nanoparticles--chemistry<br/>Neoplasm Metastasis<br/>RNA, Small Interfering--genetics<br/>Receptors, CCR--genetics<br/>T-Lymphocytes--drug effects<br/>Triple Negative Breast Neoplasms--drug therapy